Korean J Obstet Gynecol.  2010 May;53(5):416-421. 10.5468/kjog.2010.53.5.416.

The comparison of clinical features of minilaparoscopic radiofrequency myolysis with laparoscopic-assisted vaginal hysterectomy in the treatment of uterine myoma

• Choi JH
• Kim SA
• Jung H

• KMID: 2273873
• DOI: http://doi.org/10.5468/kjog.2010.53.5.416

Abstract

OBJECTIVE
To compare clinical features of minilaparoscopic radiofrequency myolysis (MLRFM) with laparoscopic-assisted vaginal hysterectomy (LAVH) in the treatment of uterine myoma.
METHODS
Between 1st January 2006 and 31th March 2009, 125 patients underwent LAVH and 125 patients underwent MLRFM by same surgeon at the University of Chosun Hospital, Department of Gynecology. We compared the age of patients, indication for treatment, myoma size, major symptom, duration of procedure, amounts of blood loss and postoperative transfusion, length of hospital day, postoperative complication and satisfaction between the two groups.
RESULTS
There were significant differences in duration of procedure between the LAVH group and the MLRFM group (69.0+/-31.6 minutes vs 43.5+/-19.8 minutes) and in the amounts of blood loss during procedure (215.2+/-215.0 mL vs 0.8+/-8.9 mL). The amounts of postoperative transfusion was 0.3+/-0.7 pints, 16 of the 125 (12.8%) for the LAVH group and no one underwent postoperative transfusion for the MLRFM group. There was significant difference in length of postoperative hospital day between the LAVH group and the MLRFM group (5.0+/-1.2 days vs 2.3+/-1.2 days). In the comparison of postoperative complications, there was no significant complication for the LAVH group, but there was major complications requiring readmission and reoperation for the MLRFM group. In MLRFM group, postoperative myoma size decreased compared to preoperative size.
CONCLUSION
We conclude that there was no treatment of choice in uterine myoma. When considering treatment of uterine myoma, we should choose appropriate method after analyzing patient characteristics, general condition, uterine myoma characteristics case by case.

Keyword

Minilaparoscopic radiofrequency myolysis

MeSH Terms

Female
Gynecology
Humans
Hysterectomy, Vaginal
Myoma
Postoperative Complications
Reoperation

Reference

1. Jung H. Use of a gonadotropin-releasing hormone agonist for the treatment of abnormal uterine bleeding and severe anemia in women with uterine myoma. Korean J Obstet Gynecol. 1996. 39:68–74.

2. Levin RJ, Levin A. Sexual pleasure: the surprising preference of 100,000 Women. Redbook. 1975. 145:51–58.

3. Yen JY, Chen YH, Long CY, Chang Y, Yen CF, Chen CC, et al. Risk factors for major depressive disorder and the psychological impact of hysterectomy: a prospective investigation. Psychosomatics. 2008. 49:137–142.

4. Graziottin A, Koochaki PE, Rodenberg CA, Dennerstein L. The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European countries. J Sex Med. 2009. 6:2143–2153.

5. Lee JJ, Choi JB, Park EH, Kim MK, Lee IS. Minimal invasive treatment of uterine myoma: Laparoscopic radiofrequency myolysis. Korean J Obstet Gynecol. 2006. 49:1212–1218.

6. Cho HH, Chung JE, Hwang SJ, Jeung IC, Kim SY, Kim MR, et al. Factors affecting the satisfaction rate of radiofrequency myolysis: 18 months follow up. Korean J Obstet Gynecol. 2007. 50:1508–1514.

7. Cho H, Lee J, Park S, Jung S, Ko K, Hong G. The effects of total and supracervical hysterectomy on sexual function. Korean J Obstet Gynecol. 2005. 48:428–435.

8. Um MJ, Kim HY, Jung H. The study of patient's satisfaction and sexual reaction after laparoscopic assisted vaginal hysterectomy and radiofrequency myolysis to the treatment for uterine myoma. Korean J Gynecol Endosc. 2009. 21:113–119.

9. Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004. 104:393–406.

10. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981. 36:433–445.

11. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol. 1990. 97:285–298.

12. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997. 90:967–973.

13. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med. 1993. 328:856–860.

14. Nisolle M, Smets M, Malvaux V, Anaf V, Donnez J. Laparoscopic myolysis with the Nd:YAG laser. J Gynecol Surg. 1993. 9:95–99.

15. Jung H, Lim JS, Chon HJ. Comparison of bipolar coagulator and ultrasonic surgical system on laparoscopy-assisted vaginal hysterectomy. J Gynecol Surg. 2005. 21:73–79.

16. Goldfarb HA. Nd:YAG laser laparoscopic coagulation of symptomatic myomas. J Reprod Med. 1992. 37:636–638.

17. Lueken RP, Gallioat A. Endoscopic surgery in gynecology. 1993. Berlin: Demeter Verlag GmBH Press;71–88.

18. Wood C, Maher P, Hill D. Myoma reduction by electrocautery. Gynecol Endosc. 1994. 3:163–165.

19. Phillips DR, Goldfarb HA. Laparoscopic leiomyoma coagulation-myolysis. Surg Technol Int. 1997. 6:187–191.

20. Lee BB. Radio frequency ablation of uterine myomas: Two-year-follow-up. AAGL 33rd Annual Meetings. 2004 Nov 10-13; San Francisco, CA, USA.

21. Kim SA, Jung H. The 1-year follow-up results of radiofrequency myolysis on uterine myomas. Korean J Obstet Gynecol. 2008. 51:1137–1141.